Abstract:ABSTRACT The induction of systemic antibody titers against hemagglutinin has long been the main focus of influenza vaccination strategies, but mucosal immunity has also been shown to play a key role in the protection against respiratory viruses. By vaccinating and challenging healthy volunteers, we demonstrated that inactivated influenza vaccine (IIV) modestly reduced the rate of influenza while predominantly boosting serum antibody titers against hemagglutinin (HA) and HA stalk, a consequence of the low neuraminidase (NA) content of IIV and the intramuscular route of administration. The viral challenge induced nasal and serum responses against both HA and NA. Correlations between mucosal IgA and serum IgG against specific antigens were low, whether before or after challenge, suggesting a compartmentalization of immune responses. Even so, volunteers who developed viral shedding for multiple days had lower baseline titers across both systemic and mucosal compartments as compared to those with no shedding or a single day of shedding. Regression analysis showed that pre-challenge HA inhibition titers were the most consistent correlate of protection across clinical outcomes combining shedding and symptoms, with NA inhibition titers and HA IgG levels only predicting the duration of shedding. Despite the inclusion of data from multiple binding and functional antibody assays against HA and NA performed on both serum and nasal samples, multivariate models were unable to account for the variability in outcomes, emphasizing our imperfect understanding of immune correlates in influenza and the importance of refining models with assessments of innate and cellular immune responses. IMPORTANCE The devastating potential of influenza has been well known for over 100 years. Despite the development of vaccines since the middle of the 20th century, influenza continues to be responsible for substantial global morbidity and mortality. To develop next-generation vaccines with enhanced effectiveness, we must synthesize our understanding of the complex immune mechanisms culminating in protection. Our study outlines the differences in immune responses to influenza vaccine and influenza infection, identifying potential gaps in vaccine-induced immunity, particularly at the level of the nasal mucosa. Furthermore, this research underscores the need to refine our imperfect models while recognizing potential pitfalls in past and future attempts to identify and measure correlates of protection.

Smoking and serological response to influenza vaccine

Smoking and Influenza-associated Morbidity and Mortality

Smoking and Influenza-associated Morbidity and Mortality: A Systematic Review and Meta-analysis

Cigarette smoking prolongs inflammation associated with influenza infection and delays its clearance in mice

Influenza Virus-Induced Lung Inflammation Was Modulated by Cigarette Smoke Exposure in Mice

Exposure to Cigarette Smoke Inhibits the Pulmonary T-cell Response to Influenza Virus and Mycobacterium Tuberculosis.

Long-term cigarette smoke exposure dysregulates pulmonary T cell response and IFN-γ protection to influenza virus in mouse

Early IFN-β administration protects cigarette smoke exposed mice against lethal influenza virus infection without increasing lung inflammation

Down-regulation of SARS-CoV-2 neutralizing antibodies in vaccinated smokers

Smoking changes adaptive immunity with persistent effects

Protecting effects of smoking against COVID-19: a community-based retrospective cohort study in middle- and older-aged adults

Cigarette Smoke Attenuates the RIG-I-initiated Innate Antiviral Response to Influenza Infection in Two Murine Models.

Cigarette smoking and risk of severe infectious respiratory diseases in UK adults: 12-year follow-up of UK biobank

Does Tobacco Smoking Affect Vaccine-Induced Immune Response? A Systematic Review and Meta-Analysis

Host response to influenza infections in human blood: association of influenza severity with host genetics and transcriptomic response

Smoking decreases the response of human lung macrophages to double-stranded RNA by reducing TLR3 expression

Influenza Vaccination in Adults in the United States with COPD before and after the COVID-19 Pandemic (2017–2022): A Multi-Year Cross-Sectional Study

Modeling the effects of cigarette smoke extract on influenza B virus infections in mice

Mucosal correlates of protection after influenza viral challenge of vaccinated and unvaccinated healthy volunteers

Activated Cd4(+) T Cells And Cd14(Hi)Cd16(+) Monocytes Correlate With Antibody Response Following Influenza Virus Infection In Humans

Activated CD4<SUP>+</SUP> T cells and CD14<SUP>hi</SUP>CD16<SUP>+</SUP> monocytes correlate with antibody response following influenza virus infection in humans